ILMN - Illumina Inc logo

Illumina Inc

ILMN

Illumina Inc. develops and markets sequencing and array-based solutions for genetic analysis, providing instruments, consumables, and services to genomic research centers, hospitals, and pharmaceutical companies. Key offerings include whole-genome sequencing kits and genotyping services.

โš•๏ธ Healthcare NASDAQ Listed 2000 $ USD
$1,000 invested 10 years ago โ†’$1,544today

Score Overview

1 Year
Score
Net Growth-2.94%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth3.57%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score3.8
Net Growth8.27%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth-0.73%
Rev Trend40%
Revenue Consistencyโ€”
10 Years
Score
Net Growth78.32%
Net Trend60%
Net Income Consistency
Rev Growth87.34%
Rev Trend60%
Revenue Consistency
20 Years
Score7.0
Net Growth20x
Net Trend65%
Net Income Consistency
Rev Growth24x
Rev Trend80%
Revenue Consistency
All Time
Score
Net Growth46x
Net Trend62%
Net Income Consistency
Rev Growth3432x
Rev Trend85%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Illumina Inc has ranked, year by year

Measure
Fundamentals Window

Showing 1 year ranking history by HDB Score.

Reached the top 50 on HDB Score in 1 year, the longest run being 1 in a row โ€” but not in 2021.

  • ILMN

2006: 85.0% ยท 2021: 68.0% ยท free through 2021 ยท longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-28
$ 271.90โ€”
1 Year2025-09-26
$ 91.69196.54%
5 Years2021-09-28
$ 399.03-31.86%
10 Years2016-09-28
$ 176.0554.44%
20 Years2006-09-28
$ 16.3516x
All Time2000-07-28
$ 19.0514x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 4.49B$ 825M$ 1.16B
2025$ 4.33B$ 850M$ 1.63B
2024$ 4.37B-$ 1.22B$ 1.22B
2023$ 4.50B-$ 1.16B$ 1.05B
2022$ 4.58B-$ 4.40B$ 2.03B
2021$ 4.52B$ 762M$ 1.33B
2020$ 3.23B$ 656M$ 3.47B
2019$ 3.54B$ 1.00B$ 3.41B
2018$ 3.33B$ 826M$ 3.51B
2017$ 2.75B$ 726M$ 2.14B
2016$ 2.39B$ 462M$ 1.55B
2015$ 2.21B$ 461M$ 1.38B
2014$ 1.86B$ 353M$ 1.33B
2013$ 1.42B$ 125M$ 1.16B
2012$ 1.14B$ 151M$ 1.35B
2011$ 1.05B$ 86M$ 1.18B
2010$ 902M$ 124M$ 894M
2009$ 666M$ 72M$ 693M
2008$ 573M$ 50M$ 640M
2007$ 366M-$ 278M$ 386M
2006$ 184M$ 39M$ 130M
2005$ 73M-$ 20M$ 50M
2004$ 50M-$ 6M$ 54M
2003$ 28M-$ 27M$ 32M
2002$ 10M-$ 40M$ 53M
2001$ 2M-$ 24M$ 90M
IPO2000$ 1M-$ 18M$ 117M
ILMN - Illumina Inc logo

Illumina Inc fundamental performance

Between 2015 and 2025, revenue grew from $ 2.21B to $ 4.33B and net income grew from $ 461M to $ 850M. Revenue increased in 6 of those 10 years; net income in 6.

Across Illumina Inc's full reported history, from 2000 to 2025, revenue grew from $ 1M to $ 4.33B and net income went from -$ 18M to $ 850M. Revenue increased in 85% of the years measured; net income in 62%.

Illumina Inc currently holds a 20-year HDB Score of 7.0 out of 10. How the HDB Score is calculated.

Membership

Continue ILMNโ€™s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,816 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies